Literature DB >> 3936247

Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence.

F M Collins.   

Abstract

Specific pathogen-free mice were vaccinated subcutaneously with 10(7) CFU of BCG Pasteur or BCG Glaxo and 30 or 90 days later, the mice were challenged aerogenically with Mycobacterium tuberculosis (Erdman or South Indian strains) or with M. avium. Both vaccines induced substantial levels of resistance to tuberculosis and tuberculin hypersensitivity. There was no detectable difference in the host response to the three aerogenic challenges which could be related in any way to the immunogenicity of the BCG strain or to the mouse virulence of the challenge organism. These results do not support the hypothesis that the protective activity of BCG vaccines varies, depending upon the virulence of the infecting organism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936247     DOI: 10.1016/0041-3879(85)90064-9

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  17 in total

Review 1.  Immunity to tuberculosis from the perspective of pathogenesis.

Authors:  E Wiegeshaus; V Balasubramanian; D W Smith
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

2.  Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

Authors:  R D Hubbard; C M Flory; F M Collins; C Cocito
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice.

Authors:  Giovanni Delogu; Maurizio Sanguinetti; Brunella Posteraro; Stefano Rocca; Stefania Zanetti; Giovanni Fadda
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Authors:  Ana M Aguirre-Blanco; Pauline T Lukey; Jacqueline M Cliff; Hazel M Dockrell
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

5.  Posttranslational regulation of Mycobacterium tuberculosis extracytoplasmic-function sigma factor sigma L and roles in virulence and in global regulation of gene expression.

Authors:  Elisa Dainese; Sébastien Rodrigue; Giovanni Delogu; Roberta Provvedi; Liette Laflamme; Ryszard Brzezinski; Giovanni Fadda; Issar Smith; Luc Gaudreau; Giorgio Palù; Riccardo Manganelli
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

6.  Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and survival in the host.

Authors:  Divya Tiwari; Rajnish Kumar Singh; Kasturi Goswami; Sunil Kumar Verma; Balaji Prakash; Vinay Kumar Nandicoori
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

7.  Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences.

Authors:  Z Li; A Howard; C Kelley; G Delogu; F Collins; S Morris
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

8.  DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.

Authors:  Giovanni Delogu; Amy Li; Charlene Repique; Frank Collins; Sheldon L Morris
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

9.  Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.

Authors:  M A Horwitz; B W Lee; B J Dillon; G Harth
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 10.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.